Salient Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-431	Closed	-$212K	–	158
2017 Q2	$212K	Sell	431 -1,198	-74%	-$589K	﹤0.01%	203
2017 Q1	$631K	Buy	1,629 +279	+21%	+$108K	0.01%	162
2016 Q4	$496K	Buy	+1,350	New	+$496K	0.01%	178